Clinical Trial

Boxing Training, Physical-functional Fitness and Cognitive Performance in Older Adults

Study acronym: Boxe4Ageing
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to evaluate and to compare the effects of two exercise regimes (Boxing Training -BT and Multicomponent Training -MT) and 12 weeks of follow-up on cognitive health status, physical-functional fitness, and risk of falls in community-dwelling elders. This is a quasi-experimental controlled trial using a parallel-group design. Participants will be allocated to 3 groups (i.e. BT, MT or control group \[no intervention\]). Both exercise programs (BT and MT) will last 24 weeks, twice a week, 45 minutes per session. Participants of all groups will be assessed for Senior Fitness test, and body weight at 4 moments (baseline, 12 weeks and 24 weeks of exercise and a follow-up period lasting 12 weeks). Our hypotheses are: 1. In comparison with the control group, both exercise groups (BT and MT) will positively improve their physical-functional fitness, cognitive health status and risk of falls with the interventions 2. The observed effects on physical-functional fitness, cognitive health status, and risk of falls as a result of the exercise programs will be similar. 3. During the follow-up period, both exercise groups will experiment reductions on physical-functional fitness, cognitive health status, and risk of falls.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-04-20; most recent amendment 2024-09-17.
Status change: Recruiting → Active, Not Recruiting 2024-09-17
Status change: Not Yet Recruiting → Recruiting 2023-10-02
Trial Details
NCT Number NCT05826314
Lead Sponsor Universidade do Porto
Collaborators: Foundation for Science and Technology, Portugal
Conditions Healthy People Programs
Enrollment 75 participants
Start Date 2023-10-17
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19